全文获取类型
收费全文 | 489篇 |
免费 | 25篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 4篇 |
妇产科学 | 11篇 |
基础医学 | 41篇 |
口腔科学 | 3篇 |
临床医学 | 76篇 |
内科学 | 163篇 |
皮肤病学 | 3篇 |
神经病学 | 25篇 |
特种医学 | 8篇 |
外科学 | 52篇 |
综合类 | 4篇 |
预防医学 | 44篇 |
眼科学 | 10篇 |
药学 | 41篇 |
中国医学 | 1篇 |
肿瘤学 | 31篇 |
出版年
2022年 | 3篇 |
2021年 | 11篇 |
2020年 | 14篇 |
2019年 | 9篇 |
2018年 | 5篇 |
2017年 | 13篇 |
2016年 | 8篇 |
2015年 | 7篇 |
2014年 | 18篇 |
2013年 | 34篇 |
2012年 | 35篇 |
2011年 | 28篇 |
2010年 | 32篇 |
2009年 | 22篇 |
2008年 | 27篇 |
2007年 | 20篇 |
2006年 | 12篇 |
2005年 | 31篇 |
2004年 | 25篇 |
2003年 | 17篇 |
2002年 | 18篇 |
2001年 | 9篇 |
2000年 | 16篇 |
1999年 | 12篇 |
1998年 | 2篇 |
1997年 | 6篇 |
1993年 | 2篇 |
1992年 | 7篇 |
1991年 | 9篇 |
1990年 | 9篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1983年 | 1篇 |
1980年 | 3篇 |
1979年 | 6篇 |
1978年 | 1篇 |
1974年 | 3篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 4篇 |
1969年 | 2篇 |
1968年 | 1篇 |
1967年 | 4篇 |
1966年 | 7篇 |
1965年 | 2篇 |
1960年 | 1篇 |
1940年 | 2篇 |
1938年 | 1篇 |
1923年 | 2篇 |
排序方式: 共有520条查询结果,搜索用时 31 毫秒
51.
Aaron E. Bair MD 《Academic emergency medicine》2000,7(1):104-104
Abstract: Grave Words: Notifying Survivors about Sudden, Unexpected Deaths. By Kenneth V. Iserson
Review and Self-Assessment to Accompany Emergency Medi-cine. BY JOHN M. HOWELL, JUDITH LINDEN, DONALD BARTON, and SHEREE GIVRE 相似文献
Review and Self-Assessment to Accompany Emergency Medi-cine. BY JOHN M. HOWELL, JUDITH LINDEN, DONALD BARTON, and SHEREE GIVRE 相似文献
52.
Benjamin D. Horne PhD MPH Heidi T. May PhD MSPH Jeffrey L. Anderson MD Abdallah G. Kfoury MD Beau M. Bailey BS Brian S. McClure BS Dale G. Renlund MD Donald L. Lappé MD John F. Carlquist PhD Patrick W. Fisher DO PhD Robert R. Pearson PharmD Tami L. Bair BS Ted D. Adams PhD MPH Joseph B. Muhlestein MD Intermountain Heart Collaborative Study 《The American journal of cardiology》2009,103(7):1042
53.
54.
A new simple and inexpensive device for treatment of upper limb lymphedema is described. Two days of application (approximately 12 hours) in 20 patients who otherwise maintained normal activities achieved a mean reduction of 21% of tissue swelling. 相似文献
55.
Anderson JL Jensen KR Carlquist JF Bair TL Horne BD Muhlestein JB 《The American journal of medicine》2004,116(3):158-164
PURPOSE: In 1998, the Food and Drug Administration mandated the fortification of food products with folic acid. The effect of this rule on mortality associated with homocysteine levels in patients with coronary artery disease is unknown. METHODS:We studied 2481 consecutive patients with coronary artery disease who underwent coronary angiography between 1994 and 1999, and who had baseline homocysteine measurements and at least 2 years of follow-up. Patients were divided into prefortification (1994 to 1997, n = 1595) and postfortification (1998 to 1999, n = 886) groups, as well as classified based on baseline homocysteine levels (normal to low, intermediate, and high). Homocysteine levels were measured by fluorescence polarization immunoassay. Mortality was determined by telephone survey or from a national Social Security database or hospital records. RESULTS: After implementation of the fortification rule, median homocysteine levels declined from 13.8 to 12.3 micromol/L (P <0.001), and the proportion of patients with high homocysteine levels (>15 micromol/L) decreased from 41% (n = 650) to 28% (n = 249) (P <0.001). Overall, homocysteine was a modest risk factor for mortality (adjusted relative risk [RR] = 1.03 per micromol/L; 95% confidence interval [CI]: 1.01 to 1.05; P = 0.006). There was no significant interaction between fortification status and homocysteine category with mortality (P for interaction = 0.85). Two-year mortality was reduced minimally (7.8% [n = 124] to 7.2% [n = 64]; RR = 0.93; 95% CI: 0.68 to 1.27; P = 0.63; adjusted RR = 0.97; 95% CI: 0.68 to 1.40), but was consistent with the expectation of a modest reduction in homocysteine levels. CONCLUSION: Homocysteine is an independent, graded risk factor for mortality. Homocysteine levels decreased modestly after the fortification of food with folic acid, but the effects on mortality were minor and likely attributable to other factors, indicating the need for more aggressive measures to reduce homocysteine-associated cardiovascular risk. 相似文献
56.
Anderson JL Muhlestein JB Bair TL Morris S Weaver AN Lappé DL Renlund DG Pearson RR Jensen KR Horne BD 《The American journal of cardiology》2005,95(9):1097-1099
A recent European case-control study suggested that statins increase the risk for polyneuropathy, a rare but serious neurologic condition. This risk was assessed in 272 patients with idiopathic polyneuropathy and 1,360 matched controls in the Intermountain Health Care electronic database. It was found that statin use before diagnosis was not significantly greater in patients than controls (odds ratio 1.30, 95% confidence interval 0.3 to 2.1, p = 0.27), nor were doses different between patients and controls. 相似文献
57.
58.
59.
Duffin DC Muhlestein JB Allisson SB Horne BD Fowles RE Sorensen SG Revenaugh JR Bair TL Lappe DL 《The Journal of invasive cardiology》2001,13(5):354-362
BACKGROUND: Vascular access site management is crucial to safe, efficient and comfortable diagnostic or interventional transfemoral percutaneous coronary procedures. Two new femoral access site closure devices, Perclose and Angio-Seal , have been proposed as alternative methods to manual compression (MC). We compared these two devices and tested them in reference to standard MC for safety, effectiveness and patient preference. METHODS: Prospective demographic, peri-procedural, and late follow-up data for 1,500 patients undergoing percutaneous coronary procedures were collected from patients receiving femoral artery closure by MC (n = 469), Perclose (n = 492), or Angio-Seal (n = 539). Peri-procedural, post-procedural, and post-hospitalization endpoints were: 1) safety of closure method; 2) efficacy of closure method; and 3) patient satisfaction. RESULTS: Patients treated with Angio-Seal experienced shorter times to hemostasis (p < 0.0001, diagnostic and interventional) and ambulation (diagnostic, p = 0.05; interventional, p < 0.0001) than those treated with Perclose. Those treated with Perclose experienced greater access site complications (Perclose vs. Angio-Seal, p = 0.008; Perclose vs. MC, p = 0.06). Patients treated with Angio-Seal reported greater overall satisfaction, better wound healing and lower discomfort (each vs. Perclose or vs. MC, all p < or = 0.0001). For diagnostic cath only, median post-procedural length of stay was reduced by Angio-Seal (Angio-Seal vs. MC, p < 0.0001; Angio-Seal vs. Perclose, p = 0.009). No difference was seen in length of stay for interventional cases. CONCLUSIONS: Overall, Angio-Seal performed better than Perclose or MC in reducing time to ambulation and length of stay among patients undergoing diagnostic procedures. There was a higher rate of successful deployment and shorter time to hemostasis for Angio-Seal, and this was accomplished with no increase in bleeding complications throughout the follow-up. Additionally, Angio-Seal performed better than Perclose in exhibiting a superior 30-day patient satisfaction and patient assessment of wound healing with less discomfort. 相似文献